(Q34761204)

4 August 2017

1 reference

title

AT(1)-receptor blockade and the kidney: importance of non-ACE pathways in health and disease (English)

1 reference

4 August 2017

Hollenberg NK

1

1 reference

4 August 2017

publication date

1 August 2002

1 reference

Journal of Human Hypertension

4 August 2017

published in

1 reference

4 August 2017

volume

16 Suppl 3

1 reference

4 August 2017

page(s)

S59-63

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001441

4 August 2017

exact match

0 references

cites work

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

Is there a future for renin inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

Angiotensin II-forming pathways in normal and failing human hearts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

Renal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001441

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001441

1 reference

Dimensions Publication ID

4 August 2017

1044199769

0 references

1 reference